MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits

MPR Drug News

Combo Drug for HCV GT-4, 5 Meets Primary Endpoint in Study

Ledipasvir in combination with sofosbuvir achieved sustained virologic response rates 12 weeks after treatment (SVR12) in 93% and 95% patients with chronic hepatitis C virus (HCV) genotypes 4 or 5 infections, respectively, a study has shown.

Cyramza Gains Colon Cancer Indication

The Food and Drug Administration (FDA) has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Numerous Injectable Products Recalled Due to Foreign Matter

Mylan announced a voluntary recall of multiple injectable products due to the potential presence of visible foreign particulate matter.

Is Dog Flu a Concern for Humans?

Canine influenza (or dog flu) is a contagious respiratory disease in dogs caused by specific Type A influenza viruses known to infect dogs, but to date there is no evidence of transmission to humans.

New "Smart" Blood Glucose Monitoring System Approved

Nipro Diagnostics announced that the Food and Drug Administration (FDA) has granted clearance for its True Metrix Air Self-Monitoring blood glucose system.